Literature DB >> 8300580

Reverse transphosphorylation by ribonuclease A needs an intact p2-binding site. Point mutations at Lys-7 and Arg-10 alter the catalytic properties of the enzyme.

E Boix1, M V Nogués, C H Schein, S A Benner, C M Cuchillo.   

Abstract

Bovine pancreatic ribonuclease A interacts with RNA along multiple binding subsites that essentially recognize the negatively charged phosphates of the substrate. This work gives additional strong support to the existence of the postulated phosphate-binding subsite p2 (Parés, X., Llorens, R., Arús, C., and Cuchillo, C. M. (1980) Eur. J. Biochem. 105, 571-579) and confirms the central role of Lys-7 and Arg-10 in establishing an electrostatic interaction with a phosphate group of the substrate. The effects of charge elimination by Lys-7-->Gln (K7Q) and/or Arg-10-->Gln (R10Q) substitutions in catalytic and ligand-binding properties of ribonuclease A have been studied. The values of Km for cytidine 2',3'-cyclic phosphate and cytidylyl-3',5'-adenosine are not altered but are significantly increased for poly(C). In all cases, kcat values are lower. Synthetic activity, i.e. the reversion of the transphosphorylation reaction, is reduced for K7Q and R10Q mutants and is practically abolished in the double mutant. Finally, the extent of the reaction of the mutants with 6-chloropurine-9-beta-D-ribofuranosyl 5'-monophosphate indicates that the phosphate ionic interaction in p2 is weakened. Thus, p2 modification alters both the catalytic efficiency and the extent of the processes in which an interaction of the phosphate group of the substrate or ligand with the p2-binding subsite is involved.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300580

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  The nuclear transport capacity of a human-pancreatic ribonuclease variant is critical for its cytotoxicity.

Authors:  Pere Tubert; Montserrat Rodríguez; Marc Ribó; Antoni Benito; Maria Vilanova
Journal:  Invest New Drugs       Date:  2010-03-30       Impact factor: 3.850

2.  A phosphate-binding subsite in bovine pancreatic ribonuclease A can be converted into a very efficient catalytic site.

Authors:  Mohammed Moussaoui; Claudi M Cuchillo; M Victòria Nogués
Journal:  Protein Sci       Date:  2007-01       Impact factor: 6.725

3.  Conformational strictness required for maximum activity and stability of bovine pancreatic ribonuclease A as revealed by crystallographic study of three Phe120 mutants at 1.4 A resolution.

Authors:  Eri Chatani; Rikimaru Hayashi; Hideaki Moriyama; Tatzuo Ueki
Journal:  Protein Sci       Date:  2002-01       Impact factor: 6.725

4.  The exo- or endonucleolytic preference of bovine pancreatic ribonuclease A depends on its subsites structure and on the substrate size.

Authors:  Claudi M Cuchillo; Mohamed Moussaoui; Tom Barman; Franck Travers; M Victòria Nogués
Journal:  Protein Sci       Date:  2002-01       Impact factor: 6.725

5.  Thermal unfolding of eosinophil cationic protein/ribonuclease 3: a nonreversible process.

Authors:  Zoran Nikolovski; Víctor Buzón; Marc Ribó; Mohammed Moussaoui; Maria Vilanova; Claudi M Cuchillo; Josep Cladera; M Victòria Nogués
Journal:  Protein Sci       Date:  2006-11-06       Impact factor: 6.725

6.  A combined kinetic and modeling study of the catalytic center subsites of human angiogenin.

Authors:  N Russo; K R Acharya; B L Vallee; R Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

7.  Functional role of glutamine 28 and arginine 39 in double stranded RNA cleavage by human pancreatic ribonuclease.

Authors:  Md Tabish Rehman; Punyatirtha Dey; Md Imtaiyaz Hassan; Faizan Ahmad; Janendra K Batra
Journal:  PLoS One       Date:  2011-03-08       Impact factor: 3.240

8.  The first crystal structure of human RNase 6 reveals a novel substrate-binding and cleavage site arrangement.

Authors:  Guillem Prats-Ejarque; Javier Arranz-Trullén; Jose A Blanco; David Pulido; M Victòria Nogués; Mohammed Moussaoui; Ester Boix
Journal:  Biochem J       Date:  2016-03-24       Impact factor: 3.857

9.  Evolutionary Trends in RNA Base Selectivity Within the RNase A Superfamily.

Authors:  Guillem Prats-Ejarque; Lu Lu; Vivian A Salazar; Mohammed Moussaoui; Ester Boix
Journal:  Front Pharmacol       Date:  2019-10-09       Impact factor: 5.810

10.  Human eosinophil-derived neurotoxin: involvement of a putative non-catalytic phosphate-binding subsite in its catalysis.

Authors:  Deepa Sikriwal; Divya Seth; Punyatirtha Dey; Janendra K Batra
Journal:  Mol Cell Biochem       Date:  2007-05-05       Impact factor: 3.842

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.